Novo Nordisk Sees Financial Giants Take Bullish Stance, Benzinga Reports

Deep-pocketed investors have adopted a bullish approach towards $Novo-Nordisk A/S (NVO.US)$, Benzinga reported, citing 21 extraordinary options activities for the stock. About 71% of the trades were leaning bullish and 19% bearish, according to the report. Four of these were puts, totaling $206,445, and 17 were calls, amounting to $1,195,302, it said.

Trading activity data signals that the investors were targeting a price range of $97.5 to $150 for Novo Nordisk over the recent three months. The stock traded at $126.69, down 0.1% at 3:16 p.m. in New York Monday. Read the full report here: Options Corner: Novo Nordisk Sees Financial Giants Take Bullish Stance

Novo Nordisk Sees Financial Giants Take Bullish Stance, Benzinga Reports

Disclaimer: Options trading entails significant risk and is not appropriate for all customers. It is important that investors read Characteristics and Risks of Standardized Options before engaging in any options trading strategies. Options transactions are often complex and may involve the potential of losing the entire investment in a relatively short period of time. Certain complex options strategies carry additional risk, including the potential for losses that may exceed the original investment amount. Supporting documentation for any claims, if applicable, will be furnished upon request. Moomoo does not guarantee favorable investment outcomes. The past performance of a security or financial product does not guarantee future results or returns. Customers should consider their investment objectives and risks carefully before investing in options. Because of the importance of tax considerations to all options transactions, the customer considering options should consult their tax advisor as to how taxes affect the outcome of each options strategy.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more